C. Renoux

First name
C.
Last name
Renoux
H. Y. Yu, O. ., Filliter, C. ., Filion, K. B., Platt, R. W., Grad, R. ., & Renoux, C. . (2024). Levothyroxine Treatment of Subclinical Hypothyroidism and the Risk of Adverse Cardiovascular Events. Thyroid. http://doi.org/10.1089/thy.2024.0227
Dimakos, J. ., Cui, Y. ., Platt, R. W., Renoux, C. ., Filion, K. B., & Douros, A. . (2024). Fluoroquinolones and the risk of severe hypoglycaemia among sulphonylurea users: Population-based cohort study. Diabetes Obes Metab. http://doi.org/10.1111/dom.15627
Simms-Williams, N. ., Treves, N. ., Yin, H. ., Lu, S. ., Yu, O. ., Pradhan, R. ., … Azoulay, L. . (2024). Effect of combination treatment with glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on incidence of cardiovascular and serious renal events: population based cohort study. Bmj, 385, e078242. http://doi.org/10.1136/bmj-2023-078242
Chiv, R. ., Beradid, S. ., Suissa, S. ., & Renoux, C. . (2024). Effectiveness and Safety of Edoxaban Compared With Apixaban in Elderly Patients With Nonvalvular Atrial Fibrillation: A Real-World Population-Based Cohort Study. Stroke. http://doi.org/10.1161/strokeaha.123.045098
Rahman, A. A., Platt, R. W., Beradid, S. ., Boivin, J. F., Rej, S. ., & Renoux, C. . (2024). Concomitant Use of Selective Serotonin Reuptake Inhibitors With Oral Anticoagulants and Risk of Major Bleeding. JAMA Netw Open, 7, e243208. http://doi.org/10.1001/jamanetworkopen.2024.3208
Douros, A. ., Ante, Z. ., Fallone, C. A., Azoulay, L. ., Renoux, C. ., Suissa, S. ., & Brassard, P. . (2024). Clinically apparent Helicobacter pylori infection and the risk of incident Alzheimer’s disease: A population-based nested case-control study. Alzheimers Dement, 20, 1716–1724. http://doi.org/10.1002/alz.13561
Engler, J. ., Filliter, C. ., Montastruc, F. ., Abenhaim, H. ., Rej, S. ., & Renoux, C. . (2024). Risk of abnormal uterine bleeding associated with high-affinity compared with low-affinity serotonin and norepinephrine reuptake inhibitors. J Affect Disord, 350, 813–821. http://doi.org/10.1016/j.jad.2024.01.163
Douros, A. ., Ante, Z. ., Fallone, C. A., Azoulay, L. ., Renoux, C. ., Suissa, S. ., & Brassard, P. . (2023). Clinically apparent Helicobacter pylori infection and the risk of incident Alzheimer’s disease: A population-based nested case-control study. Alzheimers Dement. http://doi.org/10.1002/alz.13561
Dimakos, J. ., Cui, Y. ., Platt, R. W., Renoux, C. ., Filion, K. B., & Douros, A. . (2023). Pharmacologic heterogeneity and risk of severe hypoglycemia with concomitant use of sulfonylureas and DPP-4 inhibitors: population-based cohort study. Clin Pharmacol Ther. http://doi.org/10.1002/cpt.2975
Suissa, S. ., Dell’Aniello, S. ., & Renoux, C. . (2023). The prevalent new-user design for studies with no active comparator: The example of statins and cancer. Epidemiology. http://doi.org/10.1097/ede.0000000000001628